Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Más filtros












Base de datos
Intervalo de año de publicación
1.
Prog Community Health Partnersh ; 12(3): 329-339, 2018.
Artículo en Inglés | MEDLINE | ID: mdl-30581176

RESUMEN

BACKGROUND: Safety-net populations are underrepresented in health research networks. To address this deficit, the Community Health Applied Research Network (CHARN) was created to promote integration of research in health centers (HCs). CHARN embodies a learning health system (LHS) model to advance the evidence base for improved care in safety-net settings. OBJECTIVES: We sought to identify lessons learned from the development of research infrastructure to promote the inclusion of safety-net populations in research. METHODS: We conducted nine qualitative interviews with a purposive sample of CHARN members, as well as content analysis of work plans and project reports, and identified barriers and facilitators to building research capacity in HCs. RESULTS: Lessons learned include the importance of linking research to the HC mission, encouraging mentoring, and investing in data infrastructure at HCs to tailor health services to communities. CONCLUSIONS: Findings can inform safety-net providers on the process of building research infrastructure and capacity.


Asunto(s)
Redes Comunitarias/organización & administración , Investigación Participativa Basada en la Comunidad , Proveedores de Redes de Seguridad , Poblaciones Vulnerables , Creación de Capacidad , Humanos , Área sin Atención Médica , Desarrollo de Programa , Evaluación de Programas y Proyectos de Salud , Investigación Cualitativa , Estados Unidos
2.
Health Aff (Millwood) ; 37(12): 1967-1974, 2018 12.
Artículo en Inglés | MEDLINE | ID: mdl-30633683

RESUMEN

Telehealth services have the potential to improve access to care, especially in rural or urban areas with scarce health care resources. Despite the potential benefits, telehealth has not been fully adopted by health centers. This study examined factors associated with and barriers to telehealth use by federally funded health centers. We analyzed data for 2016 from the Uniform Data System using a mixed-methods approach. Our findings suggest that rural location, operational factors, patient demographic characteristics, and reimbursement policies influence health centers' decisions about using telehealth. Cost, reimbursement, and technical issues were described as major barriers. Medicaid reimbursement policies promoting live video and store-and-forward services were associated with a greater likelihood of telehealth adoption. Many health centers were implementing telehealth or exploring its use. Our findings identified areas that policy makers can address to achieve greater telehealth adoption by health centers.


Asunto(s)
Política de Salud , Accesibilidad a los Servicios de Salud/organización & administración , Población Rural , Proveedores de Redes de Seguridad/economía , Telemedicina/organización & administración , Recolección de Datos/métodos , Humanos , Medicaid/economía , Mecanismo de Reembolso/economía , Proveedores de Redes de Seguridad/organización & administración , Telemedicina/métodos , Estados Unidos
4.
Health Aff (Millwood) ; Suppl Web Exclusives: W3-120-3, 2003.
Artículo en Inglés | MEDLINE | ID: mdl-14527243

RESUMEN

Our analysis examined the effects of the Food and Drug Administration's (FDA's) 1997 draft guidance regarding advertisements for prescription drugs broadcast directly to consumers. We found that although direct-to-consumer (DTC) advertising spending by pharmaceutical companies has increased, more than 80 percent of their promotional spending is directed to physicians. DTC advertising appears to increase the use of prescription drugs among consumers. The FDA's oversight has not prevented companies from making misleading claims in subsequent advertisements, and a recent policy change has lengthened the FDA's review process, raising the possibility that some misleading campaigns could run their course before review.


Asunto(s)
Publicidad/normas , Industria Farmacéutica/normas , Participación del Paciente , United States Food and Drug Administration , Publicidad/legislación & jurisprudencia , Decepción , Aprobación de Drogas , Industria Farmacéutica/legislación & jurisprudencia , Utilización de Medicamentos , Guías como Asunto , Humanos , Pautas de la Práctica en Medicina , Estados Unidos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...